Review highlights the development of ligand-oligonucleotide conjugates for drug discovery, suggesting their potential as efficient drug-delivery systems.
Recently, oligonucleotide-based drug discovery has attracted considerable amounts of attention. As oligonucleotide therapeutics have evolved into practical use, research into the development of functional artificial nucleic acids has been vigorously conducted worldwide. However, the synthesis of artificial nucleic acids generally requires long sequences from starting materials; hence, structurally optimizing oligonucleotide therapeutics is extremely difficult. In response to this challenge, we have been developing reactions that use oligonucleotides as starting materials. As a part of this work, we focused on ligand-oligonucleotide conjugates because the conjugates of functional ligands and oligonucleotides have attracted attention as drug-delivery systems that improve the efficacies of oligonucleotide therapeutics; they are also DNA-encoded-library-based drug-discovery tools. In this review, we broadly introduce our research into ligand-oligonucleotide conjugates.
No takes yet. Share an insight, caveat, or question.
Takashi Osawa (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: